Loïc Maurel
Directeur/Membre du Conseil chez France Biotech Association
Profil
Loïc Maurel is currently the Vice Chairman at France Biotech Association since 2013.
Previously, he served as the President & Chief Executive Officer at Debiovision, Inc. from 2001 to 2008.
He also held positions as Chairman at OncoMab GmbH, Chairman-Management Board & COO at Eurobio-Scientific SA, Director at Avance Pharma, Inc., and Director at BioQuebec.
From 2018 to 2022, he was a Director at Coretech 5 SA. Dr. Maurel also worked as Vice President-Operations & Marketing at Novartis AG, President-Management Board at Exonhit from 2010 to 2012, and Vice President-Operations & Marketing at Novartis Pharmaceuticals Canada, Inc. and Novartis Pharma SAS.
He obtained his doctorate degree from Université de Bordeaux in 1985.
Postes actifs de Loïc Maurel
| Sociétés | Poste | Début |
|---|---|---|
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Directeur/Membre du Conseil | 09/08/2010 |
Anciens postes connus de Loïc Maurel
| Sociétés | Poste | Fin |
|---|---|---|
| CORETECH 5 | Directeur/Membre du Conseil | 01/04/2022 |
Exonhit
 Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Directeur Financier/CFO | 06/11/2009 |
Debiovision, Inc.
 Debiovision, Inc. Medical SpecialtiesHealth Technology Part of Debiopharm International SA, Debiovision, Inc. is a Canadian company that develops drugs and pharmaceutical products. The company is based in Montréal, Canada. Debiovision is the result of an M & A transaction between Debiopharm International SA and H3 Pharma, Inc. as of March 01, 2005. | Directeur Général | 01/01/2008 |
| NOVARTIS AG | Directeur des opérations | - |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Directeur des opérations | - |
Formation de Loïc Maurel
| Université de Bordeaux | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| EUROBIO SCIENTIFIC | Health Technology |
| CORETECH 5 | Process Industries |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 8 |
|---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Commercial Services |
Debiovision, Inc.
Debiovision, Inc. Medical SpecialtiesHealth Technology Part of Debiopharm International SA, Debiovision, Inc. is a Canadian company that develops drugs and pharmaceutical products. The company is based in Montréal, Canada. Debiovision is the result of an M & A transaction between Debiopharm International SA and H3 Pharma, Inc. as of March 01, 2005. | Health Technology |
OncoMab GmbH
 OncoMab GmbH Medical DistributorsDistribution Services OncoMab GmbH develops and markets human antibodies for cancer therapy. The company is headquartered in Wurzburg, Germany. | Distribution Services |
Avance Pharma, Inc.
 Avance Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avance Pharma, Inc. manufactures and distributes pharmaceutical products. It provides drugs for the treatment of infectious diseases, cancer and other illnesses. The company's products include enzymes, seratrodats, allergic drugs, vaccines and antihypertensive drugs. Avance Pharma was founded by Jean Archambault in December, 1997 and is headquartered in Laval, Canada. | Health Technology |
BioQuebec
 BioQuebec BiotechnologyHealth Technology BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun. | Health Technology |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Novartis Pharma SAS wholesales and distributes pharmaceutical products. It offers generic and branded drugs and medicines. The company is headquartered in Rueil-Malmaison, France. | Health Technology |
